STEPHANIE FONTANELLA: Open Payments
NPI 1407416175 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 9 payments from 8 companies in 2025. Trend: 2023 $817 · 2024 $766 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Novo Nordisk Inc | 1 | $35 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $20 |
Products named: LINZESS, EOHILIA, Wegovy, OCALIVA, XIFAXAN, VELSIPITY.
Industry payments across CT — which companies pay providers there.
